Experts At US House Subcommittee Criticize FDA’s Initial Lack Of Serology Testing Oversight

The FDA’s initial lack of oversight of the tests shows why it is important for the agency to continue its public health responsibility in ensuring safe and effective products get to market, a panel of experts told lawmakers.